NATIVE LABS LTD
Company number 14919214 · Active · London NW11 8NA
NATIVE LABS LTD is an active private limited company (company number 14919214) incorporated on 6 June 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 June 2025, showing net assets of −£7,020, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 702100% on the prior period (£1).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 6 June 2023
- Next accounts due
- 30 March 2027 — in 162 days
- Confirmation statement due
- 20 June 2027 — in 244 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 June 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£7,020 | — | — | £7,419 | — | — | 1 |
| 30 June 2024 | £1 | — | — | £21k | — | — | 1 |
- Current ratio
- 0.05 — current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 23/100 (grade E)
- -15 Negative net assets — Net assets £-7,020 at 2025-06-30
- -8 Net assets falling — -702100.0% vs prior period
- -8 Current liabilities exceed current assets — Current ratio 0.05
- +4 Past first filings — Incorporated 2023-06-06
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Louis Brookstein — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 6 June 2023
- Dr Arya Shabani — owns 25–50% of shares; holds 25–50% of voting rights · since 25 March 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- EADSVIEW LIMITED — London, inc. Jun 2023
- EXERT THERAPEUTICS LIMITED — London, inc. Jun 2023
- FULL CIRCLE BIOTECHNOLOGY LTD — London, inc. Jun 2023
- GENKA BIO LTD — London, inc. Jun 2023
- TROGENIX LTD — London, inc. Jun 2023
- CRANE BIOSCIENCES LTD — London, inc. May 2023
Reminders for NATIVE LABS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.